Clinical Trial Update: Hydroquinidine Versus Placebo in Patients With Brugada Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating hydroquinidine versus placebo in Brugada syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brugada Syndrome

Drugs mentioned

• Hydroquinidine (hydroquinidine)

Snippet

Sponsor: Nantes University Hospital | Conditions: Brugada Syndrome | Phase 3 | Status: TERMINATED